Results

Total Results: 978 records

Showing results for "adverse drug events".
Users also searched for: pressure injury

21. Integrating stakeholder preferences in comparative effectiveness research using multi-criteria decision analysis (MCDA) and Conjoint Analysis (CA) (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/mcda-ijzerman.pdf
    January 01, 2011 - Integrating stakeholder preferences in comparative effectiveness research using multi-criteria decision analysis (MCDA) and Conjoint Analysis (CA) Slide 1 Integrating stakeholder preferences in comparative effectiveness research using multi-criteria decision analysis (MCDA) and Conjoint Analysis (CA) Maarten J…

22. Dia 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/ijzerman_ahrq-webinar-mcda.pdf
    January 01, 2011 - Dia 1 1 Integrating stakeholder preferences in comparative effectiveness research using multi-criteria decision analysis (MCDA) and Conjoint Analysis (CA) Maarten J. IJzerman, PhD Professor and chair, department Health Technology & Services Research m.j.ijzerman@utwente.nl Multiple endpoints in …

23. S89 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s89.pdf
    October 01, 2007 - Prompt, active, population-based identification of adverse drug reaction signals.

24. Rheumatoid-Arthritis-Medicine Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
    April 01, 2012 - 1 Comparative Effectiveness Review Number 55 Drug Therapy for Rheumatoid Arthritis in Adults: An Update Executive Summary Background Rheumatoid arthritis (RA), which affects 1.3 million adult Americans, is an autoimmune disease that involves inflammation of the synovium (a thin layer of tissue lining a joint …

25. S108 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s108.pdf
    October 01, 2007 - drug reaction or other medical injury. … The costs of adverse drug events in hospitalized patients. … Adverse Drug Events Prevention Study Group. JAMA. 1997;277:307–311. 21. … Adverse drug events in hospitalized patients. … Using a hospital information system to assess the effects of adverse drug events.

26. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - CER #55: Drug Therapy for Rheumatoid Arthritis in Adults: An Update Original release date: April, 2012 Surveillance Report: May, 2013 Key Findings: • For Key Question 1, conclusion on comparative effectiveness of biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs) is probably out of date. Conclu…

27. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - CER #55: Drug Therapy for Rheumatoid Arthritis in Adults: An Update Original release date: April, 2012 Surveillance Report: May, 2013 Key Findings: • For Key Question 1, conclusion on comparative effectiveness of biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs) is probably out of date. Conclu…

28. Medical Care Journal Supplement (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/toc.pdf
    January 01, 2007 - Developing Indicators of Inpatient Adverse Drug Events Through Non-Linear Analysis Using Administrative … Evaluation and Overview of the National Electronic Injury Surveillance System- Cooperative Adverse … Drug Event Surveillance Project (NEISS-CADES).

29. CER 218 Disposition of Comments: Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
    April 23, 2019 - Statements about the risk of potential adverse drug reactions are made without the rigor that is applied … Esophageal cancer is not a class specific adverse drug reaction for either bisphosphonates or denosumab … increased fracture risk) and hypothetical benefits (reduced risk of AFFs, ONJ and other potential adverse … drug reactions) of discontinuing treatment with a bisphosphonate after 3 to 5 years (i.e., taking

30. EHC Protocol: Making Healthcare Safer IV: Deprescribing to Reduce Medication Harms in Older Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/deprescribing-protocol.pdf
    July 01, 2023 - drug events (ADEs), increased healthcare utilization (e.g., emergency department visits, acute care … drug events, adverse drug withdrawal events, mortality) Implementation measures (e.g., barriers … Adverse drug events in ambulatory care. … Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. … Reducing Adverse Drug Events in Older Adults.

31. Antipsychotics-Children Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
    June 04, 2010 - National Library of Medicine’s TOXLINE® and MedEffectTM Canada Adverse Drug Reaction Database.

32. Making Healthcare Safer IV_Rapid Response_Deprescribing To Reduce Medication Harms in Older Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-deprescribing.pdf
    February 01, 2024 - drug event; ADWE = adverse drug withdrawal event; CI = confidence interval; ED = emergency department … Adverse drug events in ambulatory care. … Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. … Reducing Adverse Drug Events in Older Adults. … Drug Events in Older Adults.

33. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_executive.pdf
    June 01, 2011 - Layout 1 Background Almost 75 million American adults— approximately one-third—have hypertension. The prevalence of hypertension increases with advancing age such that more than half of people 55 to 74 years old and approximately three-fourths of those age 75 years and older are affected. In addition to being the pr…

34. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
    June 01, 2017 - Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update Comparative Effectiveness Review Number 191 Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update Executive Summary Introduction Major orthopedic surgery carries a high risk for venous …

35. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
    June 01, 2017 - Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update Comparative Effectiveness Review Number 191 Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update Executive Summary Introduction Major orthopedic surgery carries a high risk for venous …

36. CER 215 Executive Summary: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-executive-summary.pdf
    March 01, 2019 - CER 215 Executive Summary: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults Purpose of Review To assess adverse events of antidepressants in the treatment of major depressive disorder in adults 65 years of age or older. Key Messages In people 65 years of age or older: • Serotoni…

37. Psoriatic Arthritis Surveillance Assesment_CER 54_Low (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
    March 01, 2013 - Psoriatic Arthritis Surveillance Assesment_CER 54_Low CER #54: Drug Therapy for Psoriatic Arthritis in Adults: Update of a 2007 Report Original release date: June 2012 Surveillance Report: March 2013 Key Findings: - Key Question 1: Conclusion regarding biologic Disease- Modifying Antirheumatic D…

38. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
    May 07, 2010 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: May 07, 2010 Evidence-based Practice Center Systematic Review Protocol Project Title: Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors (ACEIs) …

39. Management of Primary Headache During Pregnancy: Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/headaches-pregnancy.pdf
    March 23, 2019 - OR “Tetracyclic antidepressant” OR mirtazapine OR “Somatostatin analog” OR octreotide) AND ("drug-related … side effects and adverse reactions"[MESH] OR “abnormalities, drug- induced”[MESH] OR birth defect OR

40. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-adults_research-protocol.pdf
    December 01, 2010 - National Library of Medicine’s TOXLINE® database and the MedEffectTM Canada Adverse Drug Reaction Database